Evidence map›Paper›PMID 30210947›Full record

ArticleCureus2018

The Potential Use of 11C-Choline Positron Emission Tomography/Computed Tomography to Monitor the Treatment Effects of Radium-223 in a Patient with Prostate Cancer.

Kazuhiro Kitajima, Shingo Yamamoto, Norihiko Kamikonya, Yukako Nakanishi, Yusuke Yamada, Takahiko Hashimoto, Toru Suzuki, Shuken Go, Akihiro Kanematsu, Michio Nojima and 1 more

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 90% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Kazuhiro KitajimaRadiology, Hyogo College of Medicine, Nishinomiya, JPN.
Shingo YamamotoUrology, Hyogo College of Medicine, Nishinomiya, JPN.
Norihiko KamikonyaRadiology, Hyogo College of Medicine, Nishinomiya, JPN.
Yukako NakanishiUrology, Hyogo College of Medicine, Nishinomiya, JPN.
Yusuke YamadaUrology, Hyogo College of Medicine, Nishinomiya, JPN.
Takahiko HashimotoUrology, Hyogo College of Medicine, Nishinomiya, JPN.
Toru SuzukiUrology, Hyogo College of Medicine, Nishinomiya, JPN.
Shuken GoUrology, Hyogo College of Medicine, Nisnomiya, JPN.
Akihiro KanematsuUrology, Hyogo College of Medicine, Nishinomiya, JPN.
Michio NojimaUrology, Hyogo College of Medicine, Nishinomiya, JPN.
Koichiro YamakadoRadiology, Hyogo College of Medicine, Nishinomiya, JPN.
Hyogo Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report here about a 59-year-old man with bone metastatic castration-resistant prostate cancer and biochemical progression, who underwent radium-223 (Ra-223) therapy, following previous treatment failure. Treatment response of osseous metastases was assessed with three

Indexed as

cholinepetprostate cancerra-223

Identifiers

PMID30210947
PMCPMC6130589
OpenAlexW2860888260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.